Mashup Score: 9
JAMA NetworkThis cohort study examines the risk of breakthrough SARS-CoV-2 infection, hospitalizations, and mortality due to COVID-19 in vaccinated patients with cancer compared with vaccinated patients without cancer between December 2020 and November 2021.
COVID-19 still relevant unfortunately and more relevant for our patients with cancer.